GE HealthCare Technologies's EBIT is $2.4B, above the sector sector average of $-18M.
Get informed when a big investor buys or sells
+ FollowAs of Jun 30, 2026
Trailing 12 months ending Jun 30, 2026
GE HealthCare Technologies (GEHC) currently reports a EBIT of $2.4B as of June 2026. That compares with $3.1B in the prior-year period — down 21.7% year over year. That is above the sector sector average of $-18M. Use the charts on this page to explore GE HealthCare Technologies's EBIT history and peer comparisons.
GE HealthCare Technologies's EBIT decreased from $3.1B to $2.4B — a 21.7% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
GE HealthCare Technologies's EBIT of $2.4B is higher than the its sector sector average of $-18M. That is roughly 13759.9% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
GE HealthCare Technologies reported $2.4B in EBIT as of June 2026. That compares with $3.1B in the prior-year period — down 21.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current EBIT of $2.4B, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $-18M. From there, open related valuation or income-statement pages for GE HealthCare Technologies, and consider following GEHC for alerts when major investors trade the stock.